Published in Hepatitis Weekly, February 13th, 2006
"Few studies have analyzed the evolution of HCV markers in CHC-treated patients. We have evaluated the presence or absence of serum and liver HCV-RNA, the core antigen (HCV-cAg) and the loss of specific antibodies (anti-HCV), in long-term sustained responders (SR)," wrote M. Moreno and colleagues, Hospital Central de Asturias.
"One hundred and seventy-six patients (132 SR and 44 nonresponders [NR]) were included in the study. HCV-RNA was determined in serum and liver by a commercial...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.